Source: Pharmabiz

Ribbon Biolabs: Ribbon Biolabs' costeffective, long DNA synthesis technology receives US patent

Ribbon Biolabs, the DNA synthesis company, announced that the US Patent and Trademark Office has issued US Patent US11352619 B2, covering Ribbon Biolabs' novel method for synthesizing a double

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Jodi Barrientos's photo - Interim-CEO of Ribbon Biolabs

Interim-CEO

Jodi Barrientos

CEO Approval Rating

90/100

Read more